NCT06847334 2025-02-26
A Study to Compare the Efficacy, Safety, Immunogenicity, and Pharmacokinetic Profile of HLX17 Vs. Keytruda® in the First-Line Treatment of Advanced Non-squamous Non-small Cell Lung Cancer
Shanghai Henlius Biotech
Phase 3 Not yet recruiting